Results 51 to 60 of about 1,240,530 (301)

Chronic granulomatous disease. Update and review

open access: yesRevista Alergia México, 2019
Chronic granulomatous disease (CGD) is a primary immunodeficiency syndrome which is characterized by increased susceptibility to severe fungal and bacterial infections.
Itzel López-Hernández   +4 more
doaj   +1 more source

Customer 360-degree Insights in Predicting Chronic Diabetes [PDF]

open access: yesarXiv, 2021
Chronic diseases such as diabetes are quite prevalent in the world and are responsible for a significant number of deaths per year. In addition, treatments for such chronic diseases account for a high healthcare cost. However, research has shown that diabetes can be proactively managed and prevented while lowering these healthcare costs.
arxiv  

Differential diagnosis in ulcerative colitis in an adolescent: Chronic granulomatous disease needs extra attention

open access: yesWorld Journal of Gastrointestinal Pathophysiology, 2017
Chronic granulomatous disease (CGD) is a primary immune deficiency that is commonly diagnosed under the age of 5 years (95%) and is rarely seen in adulthood. CGD may manifest as inflammatory bowel disease (IBD) in childhood.
D. Kotlarz   +8 more
semanticscholar   +1 more source

Granulomatous Cheilitis and Crohn's Disease

open access: yesCanadian Journal of Gastroenterology, 2001
Granulomatous cheilitis is characterized by recurrent swelling of the labial tissues and granulomatous histology. Granulomatous cheilitis has been recognized as an early manifestation of Crohn's disease.
Ishfaq Ahmad, David Owens
doaj   +1 more source

NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous Disease.

open access: yesArteriosclerosis, Thrombosis and Vascular Biology, 2017
The phagocytic cell enzyme NADPH oxidase-2 (Nox2) is critical for killing micro-organisms via production of reactive oxygen species and thus is a key element of the innate immune system. Nox2 is also detectable in endothelial cells and platelets where it
F. Violi   +4 more
semanticscholar   +1 more source

CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Defining the CSF cytokine/chemokine and injury biomarker signature of glial fibrillary acidic protein (GFAP) autoimmunity can inform immunopathogenesis. CSF GFAP‐IgG‐positive samples (N = 98) were tested for 17 cytokines/chemokines, neurofilament light chain (NfL), and GFAP (ELLA, Bio‐Techne).
Yahel Segal   +11 more
wiley   +1 more source

COVID-19 in Chronic Granulomatosis Disease: A Case Report

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2022
A novel coronavirus disease known as Coronavirus Disease 2019 (COVID-19) has spread quickly throughout the world, and it was declared a pandemic in March 2022.
Hossein Esmaeilzadeh   +5 more
doaj   +1 more source

Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients

open access: yesAmerican journal of hematology/oncology, 2017
Chronic granulomatous disease (CGD) is an innate immunodeficiency with a genetic defect of the nicotinamide adenosine dinucleotide phosphate, reduced, oxidase components.
B. Wolach   +18 more
semanticscholar   +1 more source

Chronic granulomatous disease

open access: yesIndian Journal of Dermatology, Venereology and Leprology, 2005
A 2(1/2)-year-old child presented with multiple discrete granulomatous lesions on the face and flexural regions since the age of 2 months along with lymphadenopathy. The patient also had recurrent bouts of pyodermas and respiratory tract infections.
S Suprakasan   +4 more
openaire   +3 more sources

Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon

open access: yesAdvanced Therapeutics, EarlyView.
Host‐directed therapies (HDTs) represent a transformative approach in infectious disease management by targeting host factors to enhance immune responses and inhibit viral replication. This innovative strategy leverages advanced genomics and gene editing technologies, offering promising avenues for improved patient outcomes and a new horizon in ...
Amol D. Gholap   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy